160 related articles for article (PubMed ID: 37462048)
1. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation.
Ishimoto T; Yagi A; Nakajima K; Okamoto N; Yukimitsu E; Kawasaki M; Kawae Y; Hayasaka S; Ueda Y; Kimura T
Hum Vaccin Immunother; 2023 Aug; 19(2):2229222. PubMed ID: 37462048
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
Yagi A; Nakagawa S; Ueda Y; Oka E; Ikeda S; Kakuda M; Kobayashi E; Ito Y; Katayama K; Hirai K; Nakayama T; Kimura T
Cancer Sci; 2024 Mar; 115(3):916-925. PubMed ID: 38158850
[TBL] [Abstract][Full Text] [Related]
3. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare's revised HPV vaccine leaflet.
Shiomi M; Ueda Y; Abe H; Yagi A; Sakiyama K; Kimura T; Tanaka Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Okada H; Nakai H; Matsumura N; Saito J; Takagi T; Horikoshi Y; Shimura K
Hum Vaccin Immunother; 2020 Oct; 16(10):2555-2558. PubMed ID: 32243236
[No Abstract] [Full Text] [Related]
4. Intentions for catch-up HPV vaccination in Japan: an internet survey.
Nakagawa S; Yagi A; Ueda Y; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kimura T; Hirai K; Sekine M; Nakayama T; Kobayashi E; Miyagi E; Enomoto T; Kimura T
Int J Clin Oncol; 2023 Dec; 28(12):1667-1679. PubMed ID: 37776388
[TBL] [Abstract][Full Text] [Related]
5. Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation.
Larson HJ; Wilson R; Hanley S; Parys A; Paterson P
Hum Vaccin Immunother; 2014; 10(9):2543-50. PubMed ID: 25483472
[TBL] [Abstract][Full Text] [Related]
6. Patterns of HPV vaccine hesitancy among catch-up generations in Japan: A descriptive study.
Machida M; Inoue S
Vaccine; 2023 May; 41(18):2956-2960. PubMed ID: 37024410
[TBL] [Abstract][Full Text] [Related]
7. Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program.
Miyoshi A; Ueda Y; Yagi A; Kimura T; Kobayashi E; Hiramatsu K; Nakagawa S; Kimura T
Hum Vaccin Immunother; 2021 Nov; 17(11):4418-4422. PubMed ID: 35016492
[TBL] [Abstract][Full Text] [Related]
8. Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?
Yagi A; Ueda Y; Nakagawa S; Ikeda S; Kakuda M; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Mizushima T; Suzuki Y; Sekine M; Hirai K; Nakayama T; Miyagi E; Enomoto T; Kimura T
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146533
[TBL] [Abstract][Full Text] [Related]
9. Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan.
Nakagawa S; Ueda Y; Yagi A; Ikeda S; Hiramatsu K; Kimura T
Cancer Sci; 2020 Jun; 111(6):2156-2162. PubMed ID: 32248632
[TBL] [Abstract][Full Text] [Related]
10. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.
Morimoto A; Ueda Y; Egawa-Takata T; Yagi A; Terai Y; Ohmichi M; Ichimura T; Sumi T; Murata H; Kanzaki H; Nakai H; Mandai M; Yoshino K; Fujita M; Kimura T; Saito J; Sobue T; Nishikawa N; Sekine M; Enomoto T; Horikoshi Y; Takagi T
Int J Clin Oncol; 2015 Jun; 20(3):549-55. PubMed ID: 25001869
[TBL] [Abstract][Full Text] [Related]
11. Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination.
Egawa-Takata T; Ueda Y; Morimoto A; Yoshino K; Kimura T; Nishikawa N; Sekine M; Horikoshi Y; Takagi T; Enomoto T
J Obstet Gynaecol Res; 2015 Dec; 41(12):1965-71. PubMed ID: 26420072
[TBL] [Abstract][Full Text] [Related]
12. Contemplating HPV vaccination in Japan during the time of COVID-19.
Miyoshi A; Ueda Y; Kimura T
Hum Vaccin Immunother; 2021 Mar; 17(3):836-837. PubMed ID: 32961077
[TBL] [Abstract][Full Text] [Related]
13. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation.
Ueda Y; Yagi A; Abe H; Nakagawa S; Minekawa R; Kuroki H; Miwa A; Kimura T
Sci Rep; 2020 Sep; 10(1):16091. PubMed ID: 32999408
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of future cervical cancer risk in Japan, based on birth year.
Yagi A; Ueda Y; Ikeda S; Sekine M; Nakayama T; Miyagi E; Enomoto T
Vaccine; 2019 May; 37(22):2889-2891. PubMed ID: 31027925
[TBL] [Abstract][Full Text] [Related]
15. The controversy on HPV vaccination in Japan: Criticism of the ethical validity of the arguments for the suspension of the proactive recommendation.
Okita T; Enzo A; Kadooka Y; Tanaka M; Asai A
Health Policy; 2020 Feb; 124(2):199-204. PubMed ID: 31924344
[TBL] [Abstract][Full Text] [Related]
16. Attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination: a 7-year follow-up survey in Japan.
Oka E; Ueda Y; Nagase Y; Sawada M; Egawa-Takata T; Yagi A; Kakuda M; Nakagawa S; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Kimura T
Int J Clin Oncol; 2022 Aug; 27(8):1356-1363. PubMed ID: 35525903
[TBL] [Abstract][Full Text] [Related]
17. Understanding confidence in the human papillomavirus vaccine in Japan: a web-based survey of mothers, female adolescents, and healthcare professionals.
Shuto M; Kim Y; Okuyama K; Ouchi K; Ueichi H; Nnadi C; Larson HJ; Perez G; Sasaki S
Hum Vaccin Immunother; 2021 Sep; 17(9):3102-3112. PubMed ID: 34061707
[TBL] [Abstract][Full Text] [Related]
18. Gaps in detailed knowledge of human papillomavirus (HPV) and the HPV vaccine among medical students in Scotland.
McCusker SM; Macqueen I; Lough G; Macdonald AI; Campbell C; Graham SV
BMC Public Health; 2013 Mar; 13():264. PubMed ID: 23521847
[TBL] [Abstract][Full Text] [Related]
19. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
Simms KT; Hanley SJB; Smith MA; Keane A; Canfell K
Lancet Public Health; 2020 Apr; 5(4):e223-e234. PubMed ID: 32057317
[TBL] [Abstract][Full Text] [Related]
20. A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
Yagi A; Ueda Y; Nakagawa S; Masuda T; Miyatake T; Ikeda S; Abe H; Hirai K; Sekine M; Miyagi E; Enomoto T; Nakayama T; Kimura T
Cancer Sci; 2021 Sep; 112(9):3691-3698. PubMed ID: 34252250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
